The United States Rejects the Approval of Therapeutic MDMA Use
In a controversial decision, the U.S. Food and Drug Administration (FDA) has decided not to approve the therapeutic use of MDMA for the treatment of post-traumatic stress disorder (PTSD) and other psychiatric disorders. This decision represents a significant setback in the field of mental health, limiting the therapeutic options available to millions of people suffering…
